Probes For Detection Of Specific Nucleotide Sequences Or Primers For The Synthesis Of Dna Or Rna Patents (Class 536/24.3)
-
Publication number: 20140304849Abstract: The present invention provides a DNA construct that confers tolerance to transgenic corn plant. Also provided are assays for detecting the presence of the PV-ZMGT32(nk603) corn event based on the DNA sequence of the recombinant construct inserted into the corn genome and of genomic sequences flanking the insertion site.Type: ApplicationFiled: March 6, 2014Publication date: October 9, 2014Applicant: Monsanto Technology LLCInventors: Carl Frederick Behr, Gregory R. Heck, Catherine Hironaka, Jinsong You
-
Patent number: 8855939Abstract: In one embodiment, a method for analyzing data generated by probe arrays is described that comprises receiving user selections of two or more data files and an identification of one or more subsets of intensity values acquired from a biological probe array. The method includes iteratively opening each data file, identifying the selected subset of intensity values associated with each open data file, determining parameters for processing, storing the parameters and the identified intensity values, and closing the open data file prior to the subsequent iteration. The method then includes processing the stored intensity values using the parameters to identify one or more biological events.Type: GrantFiled: June 18, 2012Date of Patent: October 7, 2014Assignee: Affymetrix, Inc.Inventors: Alan J. Williams, Charles W. Sugnet, James H. Gorrell
-
Publication number: 20140298531Abstract: The present invention relates to the field of plant breeding. More specifically, the present invention includes a method of using haploid plants for genetic mapping of traits of interest such as disease resistance. Further, the invention includes a method for breeding corn plants containing quantitative trait loci (QTL) that are associated with resistance to Gray Leaf Spot, a fungal disease associated with Cercospora spp.Type: ApplicationFiled: June 17, 2014Publication date: October 2, 2014Inventors: Michael R. Kerns, Hongwu Jia, David Butruille, Travis J. Frey, Gilberto Pozar, Kevin Cook, Scott Walker, Gregory Holland
-
Publication number: 20140296504Abstract: The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for and/or develop or design agents capable of inhibiting infection, replication and/or release of the virus.Type: ApplicationFiled: November 26, 2013Publication date: October 2, 2014Applicant: ABL SAInventors: Angeline Ingrid Bartholomeusz, Stephen Alister Locarnini, Anna Ayres, Danielle Colledge, Joseph Sasadeusz, Peter William Angus, William Sievert
-
Patent number: 8846313Abstract: A device comprising a rigid substrate, a flexible cover element at least partially covering the substrate, a first structure formed in the substrate, adapted for accommodating liquids and adapted for releasing contents of one or more cells, spores, or viruses, the contents including the target molecules, a second structure formed in the substrate, adapted for accommodating liquids and comprising at least one binding member adapted for capturing the target molecules and for determining a value indicative of the presence and/or amount of the target molecules, a micro fluidic network interconnecting at least the first structure and the second structure, and an actuator member adapted for effecting a fluid flow between the first structure and the second structure by pressing the flexible cover element against the substrate to selectively close a portion of the micro fluidic network.Type: GrantFiled: November 6, 2007Date of Patent: September 30, 2014Assignee: Clondiag GmbHInventors: Katrin Steinmetzer, Eugen Ermantraut, Torsten Schulz, Thomas Kaiser, Thomas Ullrich
-
Patent number: 8846316Abstract: The disclosure relates to a method for determining incidence of liver cancer in a subject, including detecting methylation level or expression level of one microRNA miR-129-2 in a bio-sample from the subject. In the case that the methylation level of the microRNA in the bio-sample is higher or the expression level of the microRNA in the bio-sample is lower relative to that of the corresponding microRNA in a control sample, indicates that the subject is predisposed to or afflicted with liver cancer.Type: GrantFiled: November 26, 2012Date of Patent: September 30, 2014Assignee: Industrial Technology Research InstituteInventors: Chang-Yi Lu, Meng-Tsung Tien, Cheng-Tao Wu, Yih-Huei Uen, Kai-Yuan Lin
-
Patent number: 8846349Abstract: This invention relates to a rapid method for detection and characterization of Escherichia coli bacteria serotype O157:H7 based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect E. coli O157:H7 in a food or water sample, such as a beef enrichment. The present invention further relates to replication compositions and kits for carrying out the method of the present invention.Type: GrantFiled: July 20, 2010Date of Patent: September 30, 2014Assignee: E.I. du Pont de Nemours and CompanyInventor: Frank R. Burns
-
Patent number: 8841073Abstract: The present invention relates to a method for identifying a binding site on an RNA transcript, wherein the binding site binds to one or more binding moieties. The method includes, among other things, introducing a photoreactive nucleoside into living cells wherein the living cells incorporate the photoreactive nucleoside into RNA transcripts during transcription thereby producing modified RNA transcripts; reverse transcribing the RNA of isolated cross-linked segments thereby generating cDNA transcripts with one mutation wherein the photoreactive nucleoside is transcribed to a mismatched deoxynucleoside; amplifying the cDNA transcripts thereby generating amplicons; and analyzing the sequences of the amplicons aligned against the reference sequence so as to identify the binding site, wherein the sequences of each amplicon having a mutation resulting from the introduction of the photoreactive nucleoside is considered to be a valid amplicon comprising at least a portion of a binding site on the RNA transcript.Type: GrantFiled: July 28, 2009Date of Patent: September 23, 2014Assignee: The Rockefeller UniversityInventors: Markus Landthaler, Manuel Ascano, Jr., Markus Hafner, Thomas Tuschl, Mohsen Khorshid, Lukas Burger, Mihaela Zavolan
-
Patent number: 8841429Abstract: The invention generally relates to nucleic acid ligands that specifically bind to infectious prions, and methods of diagnosing a transmissible spongiform encephalopathy disease in a subject. In certain embodiments, the invention provides an isolated nucleic acid ligand that binds to an infectious prion. In other embodiments, the invention provides a method for diagnosing a transmissible spongiform encephalopathy disease in a subject including obtaining a tissue or body fluid sample from a subject, contacting the tissue or body fluid with a nucleic acid ligand that binds to an infectious prion, thereby detecting the infectious prion in the sample, and diagnosing the transmissible spongiform encephalopathy disease based on results of the contacting step.Type: GrantFiled: November 3, 2009Date of Patent: September 23, 2014Assignee: Vivonics, Inc.Inventor: Vladimir Leo Gilman
-
Publication number: 20140272978Abstract: A method for detecting variation of gene based on fluorescence quenching quantification comprises: performing single base extension at a specific site of a gene to be detected with marked probes and marked dideoxyribonucleotide triphosphate; detecting fluorescence quenching values, and determining SNP of the gene to be detected. The present invention also provides an oligonucleotide probe for the method.Type: ApplicationFiled: October 17, 2012Publication date: September 18, 2014Inventors: Rui Shi, Bochun Huang
-
Publication number: 20140272934Abstract: The invention provides novel oligonucleotide probes that have dendrimeric dyes useful for detecting and analyzing biological samples, and compositions and methods thereof. The dendrimeric dye-containing oligonucleotide probes are useful for high sensitivity fluorescence in situ hybridization (FISH) of nucleic acids such as DNA and RNA.Type: ApplicationFiled: January 12, 2014Publication date: September 18, 2014Inventors: Jeremy Lackey, Siyuan Chen, Maithreyan Srinivasan
-
Publication number: 20140283197Abstract: This disclosure concerns compositions and methods for identifying the phytophthora resistant phenotype in soybean. In some embodiments, the disclosure concerns methods for performing marker-assisted breeding and selection of plants carrying one or more determinants of phytophthora resistance in soybean. In some embodiments, the disclosure concerns methods for detecting phytophthora resistance in soybean via the use of an amplification reaction.Type: ApplicationFiled: March 11, 2014Publication date: September 18, 2014Applicant: Dow AgroSciences LLCInventors: Yonghe Bai, Fang Lu, Tyler Mansfield, Jenelle Meyer, Robert E. Moore, Bradley Hedges, William M. Campbell, Julu Manandhar, Jan E. Backlund, David H. Meyer, Siva P. Kumpatla, Raghav Ram
-
Publication number: 20140272955Abstract: The present invention provides for novel methods and compositions for nucleic acid sequence detection. Unique, identifying cleavage fragments from probes, bound to target nucleic acids, are produced during PCR by the 5?-nuclease activity of the polymerase. The identity of the targets can be determined by identifying the unique cleavage fragments.Type: ApplicationFiled: March 10, 2014Publication date: September 18, 2014Applicant: Roche Molecular Systems, Inc.Inventor: Amar Gupta
-
Patent number: 8835114Abstract: Nucleic acid oligonucleotide sequences are disclosed which include amplification oligomers and probe oligomers which are useful for detecting multiple types of human papillomaviruses (HPV) associated with cervical cancer. Methods for detecting multiple HPV types in biological specimens by amplifying HPV nucleic acid sequences in vitro and detecting the amplified products are disclosed.Type: GrantFiled: September 30, 2013Date of Patent: September 16, 2014Assignee: Gen-Probe IncorporatedInventors: Sylvia A. Norman, Jennifer J. Bungo, William L. Hanna, Neeraj P. Rao
-
Patent number: 8835107Abstract: A new coronavirus is disclosed herein with a tropism that includes humans. Means and methods are provided for diagnosing subjects (previously) infected with the virus. Also provided are among others vaccines, medicaments, nucleic acids and specific binding members.Type: GrantFiled: July 26, 2010Date of Patent: September 16, 2014Assignee: Amsterdam Institute of Viral Genomics B.V.Inventor: Cornelia Maria Van Der Hoek
-
Patent number: 8835115Abstract: The present disclosure provides methods of identifying subjects having an increased likelihood of developing one or more adverse side effects resulting from administration of a microtubule-stabilizing agent. In particular examples, the method includes determining whether the subject has an ABCB1 predictive polymorphism for microtubule-stabilizing agent-induced toxicity, wherein the presence of such a polymorphism indicates that the subject has an increased risk of developing microtubule-stabilizing agent induced adverse effects. Examples of ABCB1 predictive polymorphisms include 2677G>T/A and 3435C>T. Also provided are methods of modifying microtubule-stabilizing agent therapy in a subject identified as having one or more ABCB1 predictive polymorphisms. Kits and isolated nucleic acid molecules that can be used in the disclosed methods are also provided.Type: GrantFiled: July 13, 2007Date of Patent: September 16, 2014Assignees: The United States of America as represented by the Secretary, Department of Health and Human Services, Universitätsklinikum FreiburgInventors: William D. Figg, Klaus Mross, Dirk Behringer, Alex Sparreboom, Tristan Sissung, Stephan Mielke
-
Publication number: 20140259227Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: ApplicationFiled: June 28, 2012Publication date: September 11, 2014Inventors: Charlene Levering, Richard Eric Cerny
-
Publication number: 20140256588Abstract: The invention relates to methods for conducting solid-phase binding assays. One example is an assay method having improved analyte specificity where specificity is limited by the presence of non-specific binding interactions.Type: ApplicationFiled: March 11, 2014Publication date: September 11, 2014Applicant: MESO SCALE TECHNOLOGIES, LLC.Inventors: Eli N. Glezer, Sudeep Kumar, Pankaj Oberoi, George Sigal, Michael Tsionsky
-
Publication number: 20140255922Abstract: Polymorphic cotton DNA loci useful for genotyping between at least two varieties of cotton. Sequences of the loci are useful for providing the basis for designing primers and probe oligonucleotides for detecting polymorphisms in cotton DNA. Polymorphisms are useful for genotyping applications in cotton. The polymorphic markers are useful to establish marker/trait associations, e.g. in linkage disequilibrium mapping and association studies, positional cloning and transgenic applications, marker-aided breeding and marker-assisted selection, hybrid prediction and identity by descent studies. The polymorphic markers are also useful in mapping libraries of DNA clones, e.g. for cotton QTLs and genes linked to polymorphisms.Type: ApplicationFiled: June 13, 2008Publication date: September 11, 2014Applicant: Monsanto Technology LLCInventors: Kunsheng Wu, John LeDeaux, David Butruille, Anju Gupta, Richard Johnson, Sam Eathington, Jason Bull, Marlin Edwards, Jinhua Xiao, Shaolin Liu, Paul McLaird
-
Publication number: 20140255924Abstract: A composition comprising population of labeled oligonucleotides is provided herein. In some embodiments, the probes are of the formula: T1-V-T2, wherein: the nucleotide sequence of the V region varies in said population; the V regions of the different oligonucleotides hybridize to sites that are tiled across a sequence in a target nucleic acid; the T1 and T2 regions do not hybridize with said target nucleic acid; within each oligonucleotide of the population, the T1 and T2 regions are not complementary; and within each oligonucleotide of the population, the T1 region is complementary to the T2 region of at least one of other oligonucleotide of the population. Also provided is a method that comprises hybridizing the population of labeled oligonucleotides with a target nucleic acid to produce a complex.Type: ApplicationFiled: March 8, 2013Publication date: September 11, 2014Applicant: AGILENT TECHNOLOGIES, INC.Inventors: NICHOLAS M. SAMPAS, Kristin Bernick
-
Publication number: 20140256789Abstract: Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids.Type: ApplicationFiled: May 19, 2014Publication date: September 11, 2014Applicants: YEDA RESEARCH AND DEVELOPMENT COMPANY LTD., ROSETTA GENOMICS, LTD.Inventors: Moshe Oren, Nina Raver-Shapira, Efi Marciano, Yael Spector
-
Patent number: 8828660Abstract: Nucleic acid oligonucleotide sequences are disclosed which include amplification oligomers and probe oligomers which are useful for detecting multiple types of human papillomaviruses (HPV) associated with cervical cancer. Methods for detecting multiple HPV types in biological specimens by amplifying HPV nucleic acid sequences in vitro and detecting the amplified products are disclosed.Type: GrantFiled: October 2, 2013Date of Patent: September 9, 2014Assignee: Gen-Probe IncorporatedInventors: Sylvia A. Norman, Jennifer J. Bungo, William L. Hanna, Neeraj P. Rao
-
Patent number: 8829169Abstract: The invention provides methods and oligonucleotide primers for assaying Brassica napus plants for the presence or absence of mutations that confer resistance to imidazolinone herbicides. Specifically, the methods and primers of the invention are useful for detecting the PM1 mutation of the B. napus AHAS1 gene and the PM2 mutation of the B. napus AHAS3 gene.Type: GrantFiled: August 21, 2009Date of Patent: September 9, 2014Assignee: Monsanto Canada Inc.Inventors: Stephen Barnes, Sigrid Vanstraelen
-
Publication number: 20140248611Abstract: Objects are to provide nucleic acid probes, which in the detection of target nucleic acids with fluorescent quenching probes, can assay a greater variety of target nucleic acids at the same time while suppressing increases in assay labor and cost, and also a method for assaying target nucleic acids by using the nucleic acid probes. Provided is a nucleic acid probe having a base sequence hybridizable with a target nucleic acid sequence in a target nucleic acid.Type: ApplicationFiled: June 18, 2012Publication date: September 4, 2014Applicant: NIPPON STEEL & SUMIKIN ECO-TECH CORPORATIONInventors: Kohei Ichikawa, Akiyoshi Hanawa, Shinya Kurata
-
Patent number: 8822149Abstract: The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. In various aspects, the invention provides methods, compositions, kits, and devices based on prognostic cancer markers, specifically melanoma prognostic markers, to aid in the prognosis and treatment of cancer.Type: GrantFiled: November 23, 2009Date of Patent: September 2, 2014Assignee: Pacific Edge LimitedInventors: Michael Alan Black, Jonathan Cebon, Parry John Guilford, Thomas John
-
Patent number: 8822673Abstract: Methods and compositions are provided for detecting a primer extension product in a reaction mixture. In the subject methods, a primer extension reaction is conducted in the presence of a polymerase having 3??5? exonuclease activity and at least one FET labeled oligonucleotide probe that includes a 3??5? exonuclease resistant quencher domain. Also provided are systems and kits for practicing the subject methods. The subject invention finds use in a variety of different applications, and are particularly suited for use in high fidelity PCR based reactions, including SNP detection applications, allelic variation detection applications, and the like.Type: GrantFiled: November 12, 2010Date of Patent: September 2, 2014Assignee: Life Technologies CorporationInventors: Quin Chou, Dragan Spasic
-
Patent number: 8815826Abstract: Provided herein are compositions and methods for the modulation of ?miR-214 for the treatment and/of prevention of fibrosis and fibroproliferative conditions.Type: GrantFiled: July 22, 2011Date of Patent: August 26, 2014Assignee: Regulus Therapeutics, Inc.Inventor: B. Nelson Chau
-
Patent number: 8815507Abstract: A two-stranded intermediary complex and cooperative hybridization method are provided. The complex has been designed so that target oligonucleotides of independent sequence can cooperatively and simultaneously hybridize to it. The cooperative hybridization mechanism is robust and modular, smoothly integrating with other dynamic DNA components to form cascaded reaction networks that can perform a variety of functions.Type: GrantFiled: March 18, 2011Date of Patent: August 26, 2014Assignee: California Institute of TechnologyInventor: David Zhang
-
Patent number: 8815509Abstract: The inventors have developed a rapid and sensitive fluorescence-based assay to quantify dNTPs. This assay relies on the principle that incorporation of a limiting dNTP is required for primer-extension and polymerase-mediated 5-3? exonuclease hydrolysis of a quenched fluorophore-labeled probe resulting in fluorescence. The concentration of limiting dNTPs is directly proportional to the fluorescence generated. This assay has important applications in research that investigates the influence of pathological conditions or pharmacological agents on dNTP biosynthesis and regulation.Type: GrantFiled: June 14, 2012Date of Patent: August 26, 2014Assignee: University of Southern CaliforniaInventors: Peter M. Wilson, Robert D. Ladner
-
Patent number: 8815514Abstract: Disclosed are methods and compositions related to real-time PCR and other nucleic acid extension or amplification reactions.Type: GrantFiled: July 2, 2010Date of Patent: August 26, 2014Assignee: Co-Diagnostics, Inc.Inventors: Brent C. Satterfield, Rebecca Garcia
-
Patent number: 8815512Abstract: The invention relates to a method for the high throughput discovery, detection and genotyping of one or more genetic markers in one or more samples, comprising the steps of restriction endonuclease digest of DNA, adaptor-ligation, optional pre-amplification, selective amplification, pooling of the amplified products, sequencing the libraries with sufficient redundancy, clustering followed by identification of the genetic markers within the library and/or between libraries and determination of (co-)dominant genotypes of the genetic markers.Type: GrantFiled: November 1, 2012Date of Patent: August 26, 2014Assignee: KeyGene N.V.Inventors: Michael Josephus Theresia Van Eijk, Anker Preben Sørensen, Marco Geradus Maria Van Schriek
-
Patent number: 8815510Abstract: In one aspect of the invention, methods for analyzing nucleic acid sample are provided. In a preferred embodiment, nucleic acids are selected using affinity matrices prior hybridization with a microarray.Type: GrantFiled: February 17, 2012Date of Patent: August 26, 2014Assignee: Affymetrix, Inc.Inventor: Stephen P. A. Fodor
-
Patent number: 8816156Abstract: The invention provides plants comprising transgenic event MON 88302 that exhibit tolerance to glyphosate herbicide. The invention also provides seeds, plant parts, cells, commodity products, and methods related to the event. The invention also provides DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a Brassica napus plant.Type: GrantFiled: June 1, 2011Date of Patent: August 26, 2014Assignee: Monsanto Technology LLCInventors: Andrew J. Brown, James F. Byrne, Robert H. Cole, James H. Crowley, John A. Miklos, Robert C. Ripley, Simone Seifert-Higgins, Jiali Xie
-
Publication number: 20140235465Abstract: A method of using Neutrilized DNA (N-DNA) as a surface probe for a high throughput detection platform is disclosed. FET and SPRi are used as high throughput detection platforms to demonstrate that the N-DNA surface probe produces good results and enhances detection sensitivity. The N-DNA modifies the charged oxygen ions (O?) on the phosphate backbone through methylation, ethylation, propylation, or alkylation, so that the backbone is not charged after this modification to increase the hybridization efficiency, sensitivity and to make the signal more clear.Type: ApplicationFiled: February 19, 2013Publication date: August 21, 2014Applicant: NATIONAL CENTRAL UNIVERSITYInventors: Wen-Yi Chen, Yun-Shyong Yang, Hardy Wai-Hong Chan
-
Patent number: 8808983Abstract: The present invention relates to certain novel shRNA molecules and methods of use thereof. According to certain embodiments of the present invention, methods for reducing the expression level of a target gene are provided. Such methods generally comprise providing a cell with one or more precursor nucleic acid sequences that encode two or more RNA molecules. A first RNA molecule comprises a double stranded sequence, which includes a guide strand sequence that is complementary to a portion of an mRNA transcript encoded by the target gene. In addition, a second RNA molecule comprises a second double stranded sequence, which includes a second guide strand sequence that is partially complementary to a portion of the mRNA transcript encoded by the target gene. Preferably, the second guide strand sequence comprises one or more bases that are mismatched with a nucleic acid sequence of the mRNA transcript encoded by the target gene.Type: GrantFiled: June 29, 2012Date of Patent: August 19, 2014Assignee: Gradalis, Inc.Inventor: Donald Rao
-
Patent number: 8809020Abstract: This invention relates to the use of tumor-derived or associated extracellular ribonucleic acid (RNA) found circulating in blood plasma or serum fraction for the detection, monitoring, or evaluation of cancer or premalignant conditions. Specifically, this invention enables the extraction of circulating RNA from plasma or serum and utilizes nucleic acid amplification assays for the identification, detection, inference, monitoring, or evaluation of any neoplasm, benign, premalignant, or malignant, in humans or other animals, which might be associated with that RNA. Further, this invention allows the qualitative or quantitative detection of tumor-derived or associated extracellular RNA circulating in the plasma or serum of humans or animals with or without any prior knowledge of the presence of cancer or premalignant tissue.Type: GrantFiled: April 24, 2007Date of Patent: August 19, 2014Assignee: OncoMEDx, Inc.Inventor: Michael S. Kopreski
-
Patent number: 8808995Abstract: Methods for genotyping polymorphisms using a locus specific primer that is complementary to a region near a selected polymorphism are described. Methods for synthesizing pools of locus specific primers that incorporate some degenerate positions are also disclosed. A plurality of different sequence capture probes are synthesized simultaneously using degenerate oligonucleotide synthesis. The sequence of the locus specific regions of the capture probes are related in that they have some bases that are identical in each sequence in the plurality of sequences and positions that vary from one locus specific region to another. The sequences are selected based on proximity to a polymorphism of interest and because they conform to a similar sequence pattern.Type: GrantFiled: January 11, 2012Date of Patent: August 19, 2014Assignee: Affymetrix, Inc.Inventors: Ketih W. Jones, Michael H. Shapero, Stephen P. A. Fodor
-
Patent number: 8808683Abstract: The present invention relates to a genetically modified bacterium of the species Listeria monocytogenes, wherein the genomic locus of the transcriptional factor PrfA has been deleted, characterized in that it comprises on genomic level an artificial sequence that acts as internal amplification control, the use of this bacterium as well as a method for detecting and determining qualitatively and/or quantitatively the occurrence of wild type Listeria monocytogenes in a sample suspected to be contaminated with said micro-organism and a kit.Type: GrantFiled: April 29, 2011Date of Patent: August 19, 2014Assignee: Merck Patent GmbHInventors: Peter Rossmanith, Karin Fruehwirth, Martin Wagner, Sabine Fuchs
-
Patent number: 8809513Abstract: The present invention provides novel algorithms for designing oligonucleotides that do not substantially hybridize to a small group of unwanted transcripts, while hybridizing to most other transcripts. Such oligonucleotides are particularly useful as primers for reverse transcription. The invention also provides compositions containing oligonucleotides that do not substantially hybridize to a small group of unwanted transcripts, while hybridizing to most other transcripts.Type: GrantFiled: August 22, 2012Date of Patent: August 19, 2014Assignee: Applied Biosystems, LLCInventors: Xiaowei Wang, Xiaohui Wang, Robert Setterquist
-
Patent number: 8808984Abstract: The invention relates to a method for synthesizing templated molecules attached to the templated which directed the synthesis thereof. The method involves a template, a scaffold functional entity and a functional entity attached to a building block, which, in turn, is attached the template. The scaffold functional entity and the functional entity of the building block are both provided with complementary dimerization domains allowing the functional entities to come into close proximity when the complementary domains interact with to each other. The method may be used for generating libraries of templated molecules which may be selected for biological activity.Type: GrantFiled: July 24, 2008Date of Patent: August 19, 2014Assignee: Neuvolution A/SInventors: Henrik Pedersen, Anette Holtmann, Thomas Franch, Alex Haahr Gouliaev, Jakob Felding
-
Patent number: 8808986Abstract: Disclosed are methods for synthesizing and/or assembling at least one polynucleotide product having a predefined sequence from a plurality of different oligonucleotides. In exemplary embodiments, the methods involve synthesis and/or amplification of different oligonucleotides immobilized on a solid support, release of synthesized/amplified oligonucleotides in solution to form droplets, recognition and removal of error-containing oligonucleotides, moving or combining two droplets to allow hybridization and/or ligation between two different oligonucleotides, and further chain extension reaction following hybridization and/or ligation to hierarchically generate desired length of polynucleotide products.Type: GrantFiled: August 27, 2009Date of Patent: August 19, 2014Assignee: Gen9, Inc.Inventors: Joseph Jacobson, George Church, Larry Li-Yang Chu
-
Publication number: 20140227683Abstract: Probes and methods are described for detecting polymorphisms, including short tandem repeats, in a target nucleotide sequence. The probes include first and second regions separated by a linker sequence, with the first and second regions having discrete melting temperatures with their respective target sequences. In a first embodiment, the first and second regions are both reporter sequences; in a second embodiment, one region is an anchor sequence while the other is a reporter sequence.Type: ApplicationFiled: September 19, 2012Publication date: August 14, 2014Inventor: Ben Cobb
-
Patent number: 8802367Abstract: It is an object to provide a method of suitably analyzing the amount of gene expression of a single-cell. A method of detecting a nucleic acid comprising a step of sampling a single-cell from a sample containing at least a single-cell, a cell lysis step of lysing cell membrane of the sampled single-cell and extracting nucleic acids from the cell, a DNase treatment step of degrading DNA of the extracted nucleic acids with DNase, a step of hybridizing mRNA of the total RNA contained in the single-cell with oligo (dT) fixed onto a carrier, a step of performing reverse transcription of the mRNA hybridized with the oligo (dT) to fix cDNA derived from the single-cell onto the carrier, thereby preparing a single-cell derived cDNA library fixed onto a carrier, and a step of amplifying cDNA fixed onto the carrier and simultaneously detecting an amplification amount of the cDNA.Type: GrantFiled: April 10, 2007Date of Patent: August 12, 2014Assignee: Hitachi, Ltd.Inventors: Kiyomi Taniguchi, Hideki Kambara, Tomoharu Kajiyama
-
Patent number: 8802371Abstract: This invention relates to a rapid method for detection and characterization of STEC bacteria based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect STEC bacteria in a food or water sample, such as a beef enrichment. The present invention further relates to isolated polynucleotides, replication compositions, kits, and reagent tablets for carrying out the method of the present invention.Type: GrantFiled: September 28, 2012Date of Patent: August 12, 2014Assignee: E. I. du Pont de Nemours and CompanyInventors: Stephen Varkey, Daniel R. DeMarco, Mark A. Jensen
-
Patent number: 8802838Abstract: Described herein are methods for analyzing polymer molecules. These methods are employed for the high throughput readout of DNA and RNA molecules with single molecule sensitivity. The method of the present invention comprises (1) the electrically controlled unzipping of DNA (or RNA) double strands, and (2) the readout of the molecule's identity (or code) using one or more molecule signal detection.Type: GrantFiled: June 30, 2011Date of Patent: August 12, 2014Assignee: President and Fellows of Harvard CollegeInventors: Amit Meller, Jerome Mathe, John S. Eid
-
Patent number: 8802599Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.Type: GrantFiled: June 23, 2011Date of Patent: August 12, 2014Assignee: Rosetta Genomics, Ltd.Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald
-
Publication number: 20140220573Abstract: Disclosed embodiments concern a probe comprising one or more pairs of monomers capable of targeting a nucleic acid target. The pair of monomers may be arranged in a manner that promotes thermoinstability of the probe complex, thus producing a probe capable of locating and/or detecting a target. The probe also may comprise one or more natural or non-natural nucleotides capable of Watson-Crick base pairing with an isosequential nucleic acid target. Particular disclosed embodiments concern a method of using the disclosed probe to target nucleic acids. In particular disclosed embodiments, the probe may be incubated with a target nucleic acid and then be detected.Type: ApplicationFiled: July 19, 2012Publication date: August 7, 2014Applicant: University Of IdahoInventor: Patrick Jerzy Hrdlicka
-
Patent number: 8795960Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3? terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.Type: GrantFiled: June 8, 2009Date of Patent: August 5, 2014Assignee: Bioarray Solutions, Ltd.Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
-
Patent number: 8795967Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.Type: GrantFiled: May 13, 2013Date of Patent: August 5, 2014Assignee: Illumina, IncInventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
-
Patent number: 8796441Abstract: Identified herein are different forms of sweet and umami receptor encoding sequences that occur in different human populations. In particular, there are provided several single nucleotide polymorphisms (SNPs) that occur within the exons/coding sequence (and are therefore coding SNPs, cSNPs) of one of the three T1R genes. Some SNPs cause amino acid substitutions, while others introduce a chain termination codon, rendering a truncated product. Differences in these genes are believed to affect the sense of taste of individuals, such that individuals with different SNPs (or different haplotypes) are believed to perceive the taste of sweet or umami (e.g., glutamate) substances differently than the rest of the population. The ability to assay this allelic information is useful in the development of flavorings and flavor enhancers, as it can be used to define groups and populations who perceive tastes differently. This in turn allows the taste preferences of these groups to be addressed at the molecular level.Type: GrantFiled: April 13, 2006Date of Patent: August 5, 2014Assignee: The United States of America as represented by the Secretary of the Department of Health and Human ServicesInventors: Dennis T. Drayna, Un-Kyung Kim